The effect of oxolamine citrate on experimentally produced inflammation in the respiratory organs.
D000447:Aldehydes; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001835:Body Weight / Q000187:drug effects; D001980:Bronchi / Q000473:pathology; D006168:Guinea Pigs; D007249:Inflammation / Q000188:drug therapy*; D008168:Lung / Q000187:drug effects*; D009929:Organ Size; D010653:Phenylbutazone / Q000494:pharmacology; D011656:Pulmonary Emphysema / Q000139:chemically induced; D012140:Respiratory Tract Diseases / Q000139:chemically induced / Q000188:drug therapy*; D012965:Sodium Chloride / Q000494:pharmacology; D014132:Trachea / Q000473:pathology
D000447:Aldehydes; D000893:Anti-Inflammatory Agents; D012965:Sodium Chloride; D010653:Phenylbutazone